학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 16건 | 목록
1~20
Academic Journal
Adrian Mosquera Orgueira; Marta Sonia González Pérez; Jose Diaz Arias; Laura Rosiñol; Albert Oriol; Ana Isabel Teruel; Joaquin Martinez Lopez; Luis Palomera; Miguel Granell; Maria Jesus Blanchard; Javier de la Rubia; Ana López de la Guia; Rafael Rios; Anna Sureda; Miguel Teodoro Hernandez; Enrique Bengoechea; María José Calasanz; Norma Gutierrez; Maria Luis Martin; Joan Blade; Juan-Jose Lahuerta; Jesús San Miguel; Maria Victoria Mateos; the PETHEMA/GEM Cooperative Group
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-9 (2022)
Academic Journal
Mateo, G.; Montalbán, M.A.; Vidriales, M.-B.; Lahuerta, J.J.; Mateos, M.V.; Gutiérrez, N.; Rosiñol, L.; Montejano, L.; Bladé, J.; Martínez, R.; De La Rubia, J.; Diaz-Mediavilla, J.; Sureda, A.; Ribera, J.M.; Ojanguren, J.M.; De Arriba, F.; Palomera, L.; Terol, M.J.; Orfao, A.; San Miguel, J.F.
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 2008, 26(16):2737-2744)
Academic Journal
Cirino Botta; Cristina Perez; Marta Larrayoz; Noemi Puig; Maria-Teresa Cedena; Rosalinda Termini; Ibai Goicoechea; Sara Rodriguez; Aintzane Zabaleta; Aitziber Lopez; Sarai Sarvide; Laura Blanco; Daniele M. Papetti; Marco S. Nobile; Daniela Besozzi; Massimo Gentile; Pierpaolo Correale; Sergio Siragusa; Albert Oriol; Maria Esther González-Garcia; Anna Sureda; Felipe de Arriba; Rafael Rios Tamayo; Jose-Maria Moraleda; Mercedes Gironella; Miguel T. Hernandez; Joan Bargay; Luis Palomera; Albert Pérez-Montaña; Hartmut Goldschmidt; Hervé Avet-Loiseau; Aldo Roccaro; Alberto Orfao; Joaquin Martinez-Lopez; Laura Rosiñol; Juan-José Lahuerta; Joan Blade; Maria-Victoria Mateos; Jesús F. San-Miguel; Jose-Angel Martinez Climent; Bruno Paiva; the Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group; the iMMunocell study group
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Academic Journal
Academic Journal
Lucia Lopez-Anglada; Cecilia Cueto-Felgueroso; Laura Rosiñol; Albert Oriol; Ana Isabel Teruel; Ana Lopez de la Guia; Enrique Bengoechea; Luis Palomera; Felipe de Arriba; Jose Mariano Hernandez; Miquel Granell; Francisco Javier Peñalver; Ramon Garcia-Sanz; Juan Besalduch; Yolanda Gonzalez; Rafael Benigno Martinez; Miguel Teodoro Hernandez; Norma C Gutierrez; Paloma Puerta; Antonio Valeri; Bruno Paiva; Joan Blade; Maria-Victoria Mateos; Jesus San Miguel; Juan Jose Lahuerta; Joaquin Martinez-Lopez; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group
PLoS ONE, Vol 13, Iss 9, p e0203392 (2018)
Academic Journal
Lasa M; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Notarfranchi L; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Agullo C; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; Gonzalez C; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Castro S; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; Perez JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; Burgos L; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Guerrero C; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Calasanz MJ; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Flores-Montero J; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; Bargay J; Hospital Universitario Son Llàtzer, IdIsBa, Palma de Mallorca, Spain.; Rios R; Hospital Virgen de las Nieves, Granada, Spain.; Cabañas V; Hospital Virgen de la Arrixaca, Murcia, Spain.; Cabrera C; Hospital San Pedro de Alcántara, Cáceres, Spain.; Martinez-Martinez R; Hospital Universitario San Carlos, Madrid, Spain.; Encinas C; Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain.; De Arriba F; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain.; Hernandez MT; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.; Palomera L; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Orfao A; Department of Medicine and Cytometry Service, Cancer Research Center (IBMCC, USAL-CSIC), University of Salamanca, CIBER-ONC CB16/12/00400, Salamanca, Spain.; Martinez-Lopez J; Hospital Universitario 12 de Octubre, University Complutense, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; San-Miguel J; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, University Complutense, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain.; Rosiñol L; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Blade J; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Cedena MT; Hospital Universitario 12 de Octubre, University Complutense, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain.; Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBER-ONC CB16/12/00233, Salamanca, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Lahuerta, Juan-Jose; Paiva, Bruno; Vidriales, Maria-Belen; Cordon, Lourdes; Cedena, Maria-Teresa; Puig, Noemi; Martinez-Lopez, Joaquin; Rosinol, Laura; Gutierrez, Norma C.; Martin-Ramos, Maria-Luisa; Oriol, Albert; Teruel, Ana-Isabel; Echeveste, Maria-Asuncion; de Paz, Raquel; de Arriba, Felipe; Hernandez, Miguel T.; Palomera, Luis; Martinez, Rafael; Martin, Alejandro; Alegre, Adrian; De la Rubia, Javier; Orfao, Alberto; Mateos, Maria-Victoria; Blade, Joan; San-Miguel, Jesus F.; GEM Cooperative Study Grp
Academic Journal
Burgos L; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Tamariz-Amador LE; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Puig N; Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.; Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Instituto de Investigación IMAS12, Madrid, Spain.; Guerrero C; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Jelínek T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Johnson S; Myeloma Center/Division of Hematology Oncology/Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Milani P; Department of Molecular Medicine, University of Pavia and Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Cordon L; Hospital Universitario La Fe, Valencia, Spain.; Perez JJ; Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.; Lasa M; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Termini R; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; Hernandez MT; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.; Palomera L; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Martinez-Martinez R; Hospital Clínico San Carlos, Madrid, Spain.; de la Rubia J; Hematology Department, University Hospital La Fe, Valencia, Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain.; Rios R; Hospital Universitario Puerta de Hierro, Hospital, Madrid, Spain.; Gonzalez ME; Hospital de Cabueñes, Gijón, Spain.; Gironella M; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Cabañas V; Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca. University of Murcia, Murcia, Spain.; Casanova M; Hematology Department, Hospital Costa del Sol Marbella, Marbella, Spain.; Krsnik I; Hospital Universitario Puerta de Hierro, Hospital, Madrid, Spain.; Perez-Montaña A; Hospital Universitario Son Espases, Palma, Spain.; González-Calle V; Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.; Rodriguez-Otero P; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Maisnar V; 4th Department of Medicine-Haematology, Charles University Hospital, Hradec Králové, Czech Republic.; Hajek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Van Rhee F; Myeloma Center/Division of Hematology Oncology/Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Jimenez-Zepeda V; Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada.; Palladini G; Department of Molecular Medicine, University of Pavia and Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Merlini G; Department of Molecular Medicine, University of Pavia and Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Orfao A; Hospital Universitario de Salamanca (HUSAL), IBSAL, Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, University of Salamanca, CIBERONC, Salamanca, Spain.; de la Cruz J; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Instituto de Investigación IMAS12, Madrid, Spain.; Martinez-Lopez J; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Instituto de Investigación IMAS12, Madrid, Spain.; Lahuerta JJ; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Instituto de Investigación IMAS12, Madrid, Spain.; Rosiñol L; Amyloidosis and Myeloma Unit. Department of Hematology. Hospital Clínic de Barcelona. IDIBAPS., Barcelona, Spain.; Blade J; Amyloidosis and Myeloma Unit. Department of Hematology. Hospital Clínic de Barcelona. IDIBAPS., Barcelona, Spain.; Mateos MV; Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.; San-Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.; Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Termini R; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Žihala D; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic.; Terpos E; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Perez-Montaña A; Hospital Universitario Son Espases, Palma, Spain.; Jelínek T; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic.; Raab M; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Weinhold N; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Mai EK; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Grab AL; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Corre J; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France.; Vergez F; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France.; Sacco A; ASST Spedali Civili di Brescia, Brescia, Italy.; Chiarini M; ASST Spedali Civili di Brescia, Brescia, Italy.; Giustini V; ASST Spedali Civili di Brescia, Brescia, Italy.; Tucci A; ASST Spedali Civili di Brescia, Brescia, Italy.; Rodriguez S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Moreno C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Perez C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Maia C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Martín-Sánchez E; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Guerrero C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Botta C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.; Garces JJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Lopez A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Tamariz-Amador LE; Prosper F; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Bargay J; Hospital Sont LLatzer, Palma de Mallorca, Spain.; Cabezudo ME; Hospital de Sant Joan Despí Moisès Broggi/ICO-H, Barcelona, Spain.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.; Hájek R; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic.; Martinez-Lopez J; Hospital Universitario 12 De Octubre, Universidad Complutense, CNIO Madrid, Spain.; Solano F; Hospital Ntra Sra del Prado, Talavera De La Reina, Spain.; Iglesias R; MD Anderson Cancer Center, Madrid, Spain.; Paiva A; Flow Cytometry Unit (UGOC), Department of Clinical Pathology, Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal.; Geraldes C; Flow Cytometry Unit (UGOC), Department of Clinical Pathology, Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal.; Vitoria H; Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal.; Gomez C; Hospital de Galdakao, Vizcaya, Spain.; De Arriba F; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain.; Ludwig H; Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna, Austria.; Garcia-Guiñon A; Hospital Universitario Arnau de Vilanova, Lleida, Spain.; Casanova M; Hospital Costa del Sol Marbella, Marbella, Spain.; Alegre A; Hospital de la Princesa, Madrid, Spain.; Cabañas V; Hospital Virgen de la Arrixaca de Murcia, IMIB Arrixaca, Universidad de Murcia, Murcia, Spain.; Sirvent M; Hospital Universitario de Donostia, San Sebastián, Spain.; Oriol A; Institut Català d'Oncologia Institut Josep Carreras, Badalona, Spain.; de la Rubia J; University Hospital de La Fe, School of Medicine and Dentistry, Catholic University of Valencia, CIBERONC CB16/12/00284, Valencia, Spain.; Hernández-Rivas JÁ; Hospital Universitario Infanta Leonor, Departamento de Medicina, Universidad Complutense, Madrid, Spain.; Palomera L; Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain.; Sarasa M; Hospital de Laredo, Laredo, Spain.; Rios P; Hospital Nuestra Señora de la Candelara, Santa Cruz de Tenerife, Spain.; Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; Flores-Montero J; Translational and Clinical Research Program, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Department of Medicine, Cytometry Service, Instituto de Investigación Biosanitaria de Salamanca (IBSAL) and CIBER-ONC (number CB16/12/00400), University of Salamanca, Salamanca, Spain.; Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Department of Medicine, Cytometry Service, Instituto de Investigación Biosanitaria de Salamanca (IBSAL) and CIBER-ONC (number CB16/12/00400), University of Salamanca, Salamanca, Spain.; Goldschmidt H; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France.; Roccaro AM; ASST Spedali Civili di Brescia, Brescia, Italy.; San-Miguel JF; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Paiva B; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Report
MInimal Residual Disease Adapted Strategy: Frontline Therapy for Patients Eligible for Autologous Stem Cell Transplantation Less Than 66 Years; a Prospective Study
Perrot A, Lambert J, Hulin C, Pieragostini A, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Mohty M, Leleu X, Manier S, Mariette C, Chaleteix C, Braun T, De Prijck B, Avet-Loiseau H, Mary JY, Corre J, Moreau P, Touzeau C; MIDAS StudyGroup . Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma. N Engl J Med. 2025 Jul 31;393(5):425-437. doi: 10.1056/NEJMoa2505133. Epub 2025 Jun 3.
Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini-Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hebraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Cherel B, Frenzel L, Vekemans MC, Bigot N, Avet-Loiseau H, Corre J, Moreau P. Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial. Blood. 2025 Jul 3;146(1):52-61. doi: 10.1182/blood.2024026230.
Mohan M, Gundarlapalli S, Szabo A, Yarlagadda N, Kakadia S, Konda M, Jillella A, Fnu A, Ogunsesan Y, Yarlagadda L, Thalambedu N, Munawar H, Graziutti M, Al Hadidi S, Alapat D, Thanendrarajan S, Zangari M, van Rhee F, Schinke C. Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. Am J Hematol. 2022 Jun 1;97(6):E195-E198. doi: 10.1002/ajh.26530. Epub 2022 Mar 21. No abstract available.
Perrot A, Lambert J, Hulin C, Pieragostini A, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Mohty M, Leleu X, Manier S, Mariette C, Chaleteix C, Braun T, De Prijck B, Avet-Loiseau H, Mary JY, Corre J, Moreau P, Touzeau C; MIDAS Study
Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini-Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hebraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Cherel B, Frenzel L, Vekemans MC, Bigot N, Avet-Loiseau H, Corre J, Moreau P. Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial. Blood. 2025 Jul 3;146(1):52-61. doi: 10.1182/blood.2024026230.
Mohan M, Gundarlapalli S, Szabo A, Yarlagadda N, Kakadia S, Konda M, Jillella A, Fnu A, Ogunsesan Y, Yarlagadda L, Thalambedu N, Munawar H, Graziutti M, Al Hadidi S, Alapat D, Thanendrarajan S, Zangari M, van Rhee F, Schinke C. Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. Am J Hematol. 2022 Jun 1;97(6):E195-E198. doi: 10.1002/ajh.26530. Epub 2022 Mar 21. No abstract available.
Academic Journal
Termini, R.; Žihala, D.; Terpos, E.; Perez-Montaña, A.; Jelínek, T.; Raab, M.; Weinhold, N.; Mai, E.K.; Grab, A.L.; Corre, J.; Vergez, F.; Sacco, A.; Chiarini, M.; Giustini, V.; Tucci, A.; Rodriguez, S.; Moreno, C.; Perez, C.; Maia, C.; Martín-Sánche, E.; Guerrero, C.; Botta, C.; Garces, J.-J.; Lopez, A.; Tamariz-Amador, L.-E.; Prosper, F.; Bargay, J.; Cabezudo, M.-E.; Ocio, E.M.; Hájek, R.; Martinez-Lope, J.; Solano, F.; Iglesias, R.; Paiva, A.; Geraldes, C.; Vitoria, H.; Gomez, C.; De Arriba, F.; Ludwig, H.; Garcia-Guiñon, A.; Casanova, M.; Alegre, A.; Cabañas, V.; Sirvent, M.; Oriol, A.; De La Rubia, J.; Hernández-Rivas, J.A.; Palomera, L.; Sarasa, M.; Rios, P.; Puig, N.; Mateos, M.-V.; Flores-Monter, J.; Orfao, A.; Goldschmidt, H.; Avet-Loisea, H.; Roccaro, A.M.; San-Miguel, J.F.; Paiva, B.; PETHEMA/GEM; iMMunocell Cooperative Groups
Academic Journal
Paiva B; Hospital Universitario de Salamanca, Spain.; Gutiérrez NC; Rosiñol L; Vídriales MB; Montalbán MÁ; Martínez-López J; Mateos MV; Cibeira MT; Cordón L; Oriol A; Terol MJ; Echeveste MA; de Paz R; de Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Sureda A; Gorosquieta A; Alegre A; Martin A; Hernández MT; Lahuerta JJ; Bladé J; San Miguel JF
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Cavo, Michele ; Sonneveld, Pieter ; Moreau, Philippe ; Bladè, Joan ; Goldschmidt, Hartmut ; Miguel, Jesús F San ; Attal, Michel ; Avet-Loiseau, Hervé ; Blau, Wolgang Igor ; Facon, Thierry ; Gutierrez, Norma ; Harousseau, Jean-Luc ; van der Holt, Bronno ; Lahuerta, Juan Jose ; Lokhorst, Henk ; Marit, Gerald ; Martin, Maria Luisa ; Marzocchi, Giulia ; Palumbo, Antonio ; Patriarca, Francesca ; Petrucci, Maria Teresa ; Rosiñol, Laura ; Salwender, Hans ; Terragna, Carolina
In Blood 16 November 2012 120(21):749-749
Academic Journal
Rosiñol, Laura ; Cibeira, María Teresa ; Mateos, Maria Victoria ; Martinez, Joaquin ; Oriol, Albert ; Teruel, Ana Isabel ; Hernández, Dolores ; García-Laraña, José ; De La Rubia, Javier ; Sureda, Anna ; Besalduch, Juan ; Palomera, Luis ; Gonzalez, Yolanda ; Etxebeste, Maria Asunción ; Díaz-Mediavilla, Joaquín ; Hernández, Miguel T. ; de Arriba, Felipe ; Alegre, Adrian ; Lahuerta, Juan José ; Miguel, Jesus F San ; Blade, Joan
In Blood 19 November 2010 116(21):307-307
Academic Journal
Paiva, Bruno; Gutiérrez, Norma Carmen; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Díaz-Mediavilla, J.; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F.
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Academic Journal
Paiva, Bruno ; Vidriales, María-Belén ; Montalbán, María-Angeles ; Mateos, María-Victoria ; Rosiñol, Laura ; Martinez, Joaquin ; Cibeira, María Teresa ; Courdón, Lourdes ; Oriol, Albert ; Terol, María José ; Echebeste, Maria-Asuncion ; de Paz, Raquel ; de Arriba, Felipe ; Palomera, Luis ; De La Rubia, Javier ; Díaz-Mediavilla, Joaquín ; Garcia-Laraña, Jose ; Sureda, Anna ; Gorosquieta, Ana ; Alegre, Adrian ; Martín, Alejandro ; Hernandez, Miguel T. ; Gonzalez, Yolanda ; Blade, Joan ; Lahuerta, Juan José ; Miguel, Jesús F. San
In Blood 19 November 2010 116(21):1910-1910
검색 결과 제한하기
제한된 항목
[검색어] the PETHEMA/GEM Cooperative Group
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어